Current FDA-approved weekly injectable GLP-1 options include: Ozempic (semaglutide, Novo Nordisk) for type 2 diabetes Wegovy (semaglutide, Novo Nordisk) for chronic weight management Mounjaro (tirzepatide, Lilly) for type 2 diabetes Zepbound (tirzepatide, Lilly) for chronic weight management Rybelsus (oral semaglutide, Novo Nordisk) for type 2 diabetes Foundayo (orforglipron, Lilly) oral, for weight management (approved April 2026) For patients who struggle specifically with weekly injections, the most practical currently available option is Foundayo (orforglipron) an oral pill requiring no injection at all
Muller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, et al
Follow your doctors instructions carefully
So, why does this weight gain happen, and how can you prevent it from even occurring
Nature 606 , 603608 (2022)
Oavsett om du vill minska fina linjer, ge huden vacker lyster eller ka fuktnivn, r den hr multifunktionella sprayen ett oumbrligt steg i din hudvrdsrutin
